Clinical Study to assess the efficacy and safety of fixed dose combination of S-Metoprolol, Atorvastatin and Ramipril tablets in hypertension coexisting with hyperlipidemia
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Atorvastatin/S-metoprolol/ramipril (Primary)
- Indications Essential hypertension; Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Emcure Pharmaceuticals
- 01 Mar 2012 Planned End Date changed to 1 Jul 2012.
- 01 Mar 2012 Status changed from completed to active, no longer recruiting.
- 16 Feb 2012 New trial record